Revealing the metabonomic variation of esophageal cancer using 1H-NMR spectroscopy and its association with the clinic pathological characteristics.
I. Sheyhidin,A. Hasim
DOI: https://doi.org/10.1200/JCO.2011.29.15_SUPPL.E14522
IF: 45.3
2011-05-20
Journal of Clinical Oncology
Abstract:e14522 Background: The aim of this study is to detect body fluid metabolites between esophageal cancer (EC) patients's vs. healthy controls to analyze the variation between patients with esophageal cancer and to explore the potential application of EC biomarkers using 1H MR-based metabonomics.
METHODS
Preoperative plasma and urine of 108 patients with EC and 50 healthy donors were subjected to the analysis by 1H-NMR spectroscopy, and after data reduction, OPLS-DA (orthogonal partial least-squares discriminate analysis) was applied for pattern recognition, and results were further evaluated by comparison with parameters of histopathology.
RESULTS
Based on the data derived from the analysis by OPLS-DA, we identified a general metabonomic profile of EC with a series of metabolites existing in a significantly lower or higher abundance in plasma of patients with EC compared to healthy donors. Leucine, alanine, isoleucine, valine, glycoprotein, lactate, acetone, acetate, choline, isobutyrate, unsaturated lipid, VLDL,LDL, 1-methylhistidinedecreased in EC patient's plasma with statistical significance (P<0.05), dimethylamine, α-glucose, β-glucose, citric acid increase in the EC patient's plasma (P <0.05). Mannitol, glutamine, r-propalanine, phenylalanine, acetic acid, allantoin, pyroracemic acid, tyrosine, β- glucose and chinoline in urine of EC patients increased significantly (P<0.05), N- acetylcysteine, valine, dihydrothymine, benzoylglycine, methylguanidine, 1-methyl-nicotinamide and citric acid decreased significantly comparing to health control's urine (P <0.05); there were significant variation between well differentiated and moderate-poorly differentiated squamous cell carcinoma, and associated with the positive rate of lymph node metastasis and the depth of invasion greater than 15 mm as well as differentiation states of cancer.
CONCLUSIONS
This study suggested that present NMR based spectrometry approach combined with statistical analysis contributed to deduce the small molecular weight metabolites as cancer biomarkers in the future.